Chongqing Lummy Pharmaceutical Co., Ltd. (SZSE: 300006)
Health Care · Pharmaceuticals · CN
CN¥5.27
-0.38% today · +8.0% 1Y
Chongqing Lummy Pharmaceutical Co., Ltd. (SZSE: 300006) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $827.78M and employs 973 people.
Over the last twelve months the share price has gained 8.0%, trading between 4.10 and 6.86.
Tweenvest scores Chongqing Lummy Pharmaceutical Co., Ltd. across four factors: quality 61/100, value 33/100, growth 0/100. Its strongest factor is quality.
300006 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $827.78M
- Revenue (TTM)
- $110.25M
- P/E
- —
- EPS
- -0.12
- Dividend yield
- —
- Beta (5Y)
- 0.41
- 52-week high
- CN¥6.86
- 52-week low
- CN¥4.10
- Avg volume (3M)
- —
- Shares outstanding
- 1.06B
- Employees
- 973
- Next earnings
- —
About Chongqing Lummy Pharmaceutical Co., Ltd.
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
- ISIN
- CNE100000H10
- Founded
- 1999
- Listed since
- Oct 30, 2009
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.